Healthtech Startups

Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries. The company operates multiple business units including Esco Scientific for laboratory equipment, Esco Medical for ART/IVF solutions, Esco Healthcare for pharma and biotech support, and Esco Aster as a CDMO offering continuous manufacturing platforms.

1 investor

Esculapia offers online medical education programs based on the USMLE standard, providing in-depth study of USMLE materials, clinical reasoning development, and professional English skills for physicians. Its teaching team includes doctors from clinics in the CIS, Israel, Germany, Canada, the US, Norway, and Finland.

1 investor

ESO builds a cloud-based emergency response ecosystem that aggregates and shares real-time data across fire, EMS, hospitals, and government agencies to improve response times and community health outcomes. The platform manages records and enables research that shapes clinical protocols and public policy.

1 investor

Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.

1 investor

Esperta Health provides an in-home and virtual wound management program that combines clinical expertise with technology to standardize care and improve healing outcomes. The platform serves patients requiring wound care management across various settings.

1 investor

ESP Management operates specialty eye care practices, providing ocular health and vision services through FDA-approved treatments and technologies. The company emphasizes quality patient care, clinical research, and compliance across its physician-led network.

1 investor

1 investor

Essential Robotics develops robotic solutions for healthcare logistics operations. The company focuses on automating material handling and supply chain processes within medical facilities.

1 investor

Essential Anesthesia Management provides anesthesia staffing and management services to hospitals, ambulatory surgery centers, and endoscopy facilities across the southeastern United States. The company supports over 150 healthcare organizations by recruiting and deploying certified registered nurse anesthetists and anesthesiologists.

1 investor

Essential Pharma develops and delivers pharmaceutical medicines for patients in niche populations, with a focus on rare disease, CNS, ophthalmology, and gastroenterology across approximately 70 countries.

1 investor

Specialty staffing company focused on providing certified medical scribes for emergency and specialty physicians

1 investor

Estia Health Limited is an Australian residential aged care provider. As of December 2023 it was acquired by an entity controlled by Bain Capital via a scheme of arrangement and delisted from the ASX; this page covers that transaction for former shareholders.

1 investor

Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction. The company is founded by experienced ophthalmology and medical device leaders with extensive track records in bringing dry eye treatments to market.

1 investor

Eterna Care develops a mobile health monitoring system that tracks vital signs, location, and health data for seniors, enabling quick emergency response and allowing family members and care professionals to monitor elderly individuals remotely. The platform combines GPS and mobile communication to support independent living and chronic condition management.

1 investor

etherFAX provides cloud-based secure document delivery and fax transmission for businesses handling sensitive information. Its solutions draw on telecommunications and cybersecurity technology to enable secure communication and document exchange.

1 investor

Ethicos Health offers an AI-enabled clinical efficacy platform that converts health plans' clinical guidelines into machine-readable algorithms and continuously evaluates longitudinal patient data to determine whether specialty medications are actually working. It is aimed at health plans seeking to reduce specialty pharmacy spend by certifying and recertifying only effective therapies and reforming the prior authorization process.

1 investor

Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.

1 investor

Etiometry develops a clinical decision support platform that uses continuous streams of physiologic data to quantify clinical risks for patients in hospital critical care and intensive care units. The company applies AI-based predictive analytics to support clinicians managing critically ill patients.

1 investor

Eucalyptus is a global telehealth provider that operates a group of digital healthcare clinics treating complex, chronic conditions and offering preventative care. It focuses on patient-directed treatment and safety across its online medicine services.

1 investor

Euclises Pharmaceuticals develops oral, small-molecule drugs targeting COX-2 to disrupt the tumor microenvironment and enhance cancer cell death, particularly when combined with immune checkpoint inhibitors or EGFR inhibitors. The company is advancing these molecules through clinical trials to improve immuno-oncology therapies.

1 investor

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

1 investor

Euler Biologics develops antibody-based therapies aimed at preserving and enhancing physical function in older adults to support healthy aging and functional independence. The company operates in the biotech and longevity space.

1 investor

EuMotus builds BodyWatch, a markerless motion capture and analysis system that uses a single camera to evaluate human movement in 3D and generate readable reports. It targets clinics, physical therapists, and athletic performance providers for injury prevention, rehabilitation, and performance assessment.

1 investor

Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers. Its pipeline is built on the ARTEMIS and E-ALPHA technology platforms aimed at targeting cancer-specific antigens.

1 investor